Genomics

Dataset Information

0

SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing [ChIP-seq]


ABSTRACT: Small Cell Lung Cancer (SCLC) can be classified into transcriptional subtypes with distinct degrees of neuroendocrine (NE) differentiation. Recent evidence supports plasticity among subtypes with a bias toward adoption of low-NE states during disease progression or upon acquired chemotherapy resistance. Here, we identify a role for SMARCA4, the catalytic subunit of the SWI/SNF complex, as a regulator of subtype shift in SCLC. SMARCA4 binds to gene loci encoding NE-lineage transcription factors ASCL1 and NEUROD1 and alters chromatin accessibility, suppressing NE programs. In parallel, SMARCA4 also controls REST, a known suppressor of the NE phenotype, by regulating SRRM4-dependent REST splicing. The SMARCA2/4 inhibitor FHD-286 induces loss of NE features and drives ERBB pathway activation in SCLC, rendering SCLC tumors sensitive to afatinib. This study nominates SMARCA4 as a key regulator of the NE state plasticity and defines a novel therapeutic strategy for SCLC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE256346 | GEO | 2024/08/28

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-28 | GSE256347 | GEO
2024-08-28 | GSE256345 | GEO
2021-07-14 | GSE158598 | GEO
2021-07-14 | GSE158593 | GEO
2022-07-05 | GSE193960 | GEO
2022-07-05 | GSE193959 | GEO
2022-08-22 | GSE211751 | GEO
2021-06-01 | GSE161741 | GEO
2021-06-01 | GSE161740 | GEO
2015-06-24 | E-GEOD-66187 | biostudies-arrayexpress